The Asahi Glass Foundation and the JST programs of PREST “Search for Nanomanufacturing Technology and Its Development” (Supervisor: Dr. Naoki Yokoyama) and Adaptable and Seamless Technology Transfer Program through Target-driven R&D have been greatly supportive in this study. We would also like to thank Dr. Jun Matsui and Dr. Takahiro Muraoka of IMRAM, Tohoku University, who provided fruitful discussion. In addition, we received generous support from Nao Naohara, Sayaka Ishibane, Akie Takanashi, Shoko Yamamoto, and Kenji Sugai in relation to the experimentation performed herein. We are very grateful to Prof. Shigefumi Kuwahara of Faculty of Agriculture, Tohoku University, for help with the organic synthesis and spectroscopic measurements.
Creation of Pure Nanodrugs and Their Anticancer Properties†
Article first published online: 11 SEP 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 124, Issue 41, pages 10461–10464, October 8, 2012
How to Cite
Kasai, H., Murakami, T., Ikuta, Y., Koseki, Y., Baba, K., Oikawa, H., Nakanishi, H., Okada, M., Shoji, M., Ueda, M., Imahori, H. and Hashida, M. (2012), Creation of Pure Nanodrugs and Their Anticancer Properties . Angew. Chem., 124: 10461–10464. doi: 10.1002/ange.201204596
- Issue published online: 1 OCT 2012
- Article first published online: 11 SEP 2012
- Manuscript Received: 13 JUN 2012
- Asahi Glass Foundation
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.